National Institute on Drug Abuse (NIDA): all 393 studies

Page 3 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 1
• Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1CompletedNCT00218517Phase 2
• Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced HyperalgesiaCompletedNCT00218374Not applicable
• Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218309
• Nicotine Lozenge to Reduce Smokeless Tobacco UseCompletedNCT00218283Phase 2
• Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco UseCompletedNCT00218270Phase 2
• Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco UseCompletedNCT00218244Phase 1/2
• Effect of Bupropion on Smoking Behavior in Smokers With SchizophreniaCompletedNCT00218231Phase 2
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaCompletedNCT00218218Phase 2
• Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of CocaineCompletedNCT00218166Phase 2
• Naltrexone Augmentation of Nicotine Patch Therapy - 1CompletedNCT00218153Phase 3
• Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1CompletedNCT00218140Phase 2
• Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing RegimensCompletedNCT00218127Phase 2
• Buprenorphine as a Treatment for Individuals Dependent on Analgesic OpioidsCompletedNCT00218101Phase 2
• Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent IndividualsTerminatedNCT00218049Phase 1
• Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2CompletedNCT00218010
• Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood SwingsCompletedNCT00217932Phase 2
• Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug UsersCompletedNCT00194480Phase 4
• A Transtheoretical Model Group Therapy for CocaineCompletedNCT00178776Phase 1
• Atomoxetine for the Treatment of Cannabis DependenceCompletedNCT00167297Phase 2
• The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 2
• Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid UsersCompletedNCT00158236Not applicable
• Rivastigmine For Methamphetamine Dependent IndividualsCompletedNCT00158210Phase 1
• Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1CompletedNCT00158171Phase 2
• Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2CompletedNCT00158158Phase 2/3
• Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2CompletedNCT00158145
• Abuse Potential of Buprenorphine/NaloxoneTerminatedNCT00149539Phase 2
• Tramadol to Reduce Opioid Withdrawal SymptomsCompletedNCT00142896Phase 2
• Effectiveness of Bupropion in Treating Marijuana Dependent IndividualsCompletedNCT00142870Phase 2
• Bupropion as an Adjunct to the Nicotine Patch Plus CBTCompletedNCT00142831Phase 4
• Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCompletedNCT00142779Not applicable
• Opioid Agonist and Antagonist Effects on Opioid DependenceTerminatedNCT00142727Phase 2
• Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1CompletedNCT00136825Phase 1
• Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2CompletedNCT00135785Phase 2
• Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2CompletedNCT00135772
• Addition of Naltrexone to Methadone TaperCompletedNCT00135759Phase 2
• Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2CompletedNCT00135746Not applicable
• A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine PatchesCompletedNCT00134927
• Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid DependenceCompletedNCT00134914Not applicable
• Blockade Efficacy of Buprenorphine/Naloxone For Opioid DependenceCompletedNCT00134888Not applicable
• Impact of Smoking Cessation on Sleep - 5CompletedNCT00132821Phase 4
• Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1CompletedNCT00129298Phase 2
• Cocaethylene as a Treatment for Cocaine Dependence - 1CompletedNCT00124696Phase 1
• Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1CompletedNCT00124683Phase 2
• Nicotine Replacement Treatment for Pregnant Smokers - 1TerminatedNCT00115687Phase 2
• Behavioral Smoking Cessation Treatment - 1CompletedNCT00110825Not applicable
• Smoking Treatment of PrisonersCompletedNCT00110630Phase 3
• Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1Status unknownNCT00100113Phase 1
• Modafinil for the Treatment of Cocaine Dependence - 1CompletedNCT00100100Phase 2
• To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1Status unknownNCT00100074Phase 1
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1Status unknownNCT00094315Phase 1
• Interactions Between Cocaine and Ethanol and Disulfiram - 1Status unknownNCT00094289Phase 1
• GBR 12909 Study in Cocaine Experienced African American Volunteers - 1Status unknownNCT00089687Phase 1
• Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Status unknownNCT00089440Phase 1
• Maintaining Abstinence in Chronic Cigarette Smokers - 1CompletedNCT00087880Phase 2
• Interaction Between Cocaine and Quetiapine - 1Status unknownNCT00087750Phase 1
• Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1Status unknownNCT00086398Phase 2
• Tiagabine for the Treatment of Cocaine Dependence - 1CompletedNCT00086255Phase 2
• Baclofen for the Treatment of Cocaine Dependence - 1CompletedNCT00082485Phase 2
• Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDSCompletedNCT00079560Phase 1/2
• Bupropion for the Treatment of Methamphetamine Dependence - 1CompletedNCT00069251Phase 2
• Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1CompletedNCT00067535Phase 1
• Incentive Programs for Female Substance Abusers Who Smoke - 3CompletedNCT00064922Phase 2/3
• Maintenance Treatment for Abstinent SmokersCompletedNCT00063323Phase 3
• Substance Dependent Teens - Impact of Treating Depression Study 1 - 1CompletedNCT00061113Phase 4
• Combination Pharmacotherapy for Smoking Cessation Among Methadone PatientsCompletedNCT00060814Phase 2
• Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1Status unknownNCT00051896Phase 1
• Chemical Dependency and Smoking Cessation: Patient's Views - 1CompletedNCT00051883
• Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1TerminatedNCT00046813Phase 4
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1Status unknownNCT00040066Phase 1
• Ondansetron for the Treatment of Methamphetamine Dependence - 1CompletedNCT00040053Phase 2
• Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Status unknownNCT00040040Phase 1
• A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1Status unknownNCT00033124Phase 2
• A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNCT00033111Phase 2
• Cocaine-Metyrapone Interaction Study - 1Status unknownNCT00033098Phase 1
• Ondansetron for the Treatment of Cocaine Dependence - 1CompletedNCT00033085Phase 2
• Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
• Assessment of Potential Interactions Between Cocaine and Tolcapone - 1Status unknownNCT00033059Phase 1
• Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Status unknownNCT00033046Phase 1
• Reserpine for the Treatment of Cocaine Dependence - 1CompletedNCT00033033Phase 2
• Lofexidine for Opiate Withdrawal - 1CompletedNCT00032942Phase 3
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
• Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1Status unknownNCT00032916Phase 1
• Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
• Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11CompletedNCT00015301Phase 4
• Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
• Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9CompletedNCT00015275Phase 4
• Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
• Modeling Impaired Judgement in Cocaine Abusers - 6CompletedNCT00015236Phase 4
• Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5CompletedNCT00015223Phase 2
• Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
• Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9CompletedNCT00015132Phase 2
• Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7CompletedNCT00015106Phase 2
• Naltrexone in Treatment of Cocaine Dependence - 5CompletedNCT00015080Phase 2
• Cocaine-Methylphendidate Interaction Study - 4CompletedNCT00015067Phase 1
• Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3CompletedNCT00015054Phase 2
• Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2CompletedNCT00015041Phase 1
• Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug UsersStatus unknownNCT00004740Not applicable
• Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With AnxietyCompletedNCT00004373Phase 2

← National Institute on Drug Abuse (NIDA) overview and focus areas